ASKG712

· AskGene Pharma, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASKG712, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration [Phase 1]